Home / Brands / Perrigo Company
Perrigo Company Recalls
106 recalls on record · December 30, 2015 to March 2, 2022 · Drugs, Food & Beverage
Recalls by year
15
16
19
20
22
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
Also filed under
The recall feeds record what looks like the same company under more than one name:
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 40 tablets per bottle. [Brand, NDC] NDC Up & Up
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 24 tablets per bottle. [Brand, NDC] NDC Care On
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 24 tablets per bottle. [Brand, NDC] NDC Being Well: 46994
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. [NDC: Brand] NDC Good Sense:0113-0852-51; NDC
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 160 tablets per bottle. [NDC: Brand] NDC CVS Health.: 6984
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 150 tablets per bottle. [NDC: Brand] NDC H.E.B.: 37808-876
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 80 tablets per bottle. [NDC: Brand] NDC Basic Care: 0113-7
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 60 tablets per bottle. [NDC: Brand] NDC Health Mart: 62011
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
March 25, 2020DrugsFDA
Perrigo Company PLC recalls Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 30 tablets per bottle. [NDC: Brand] NDC CVS Health: 69842-
Hazard: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
July 24, 2019Food & BeverageFDA
Perrigo Company PLC recalls Parent's Choice Advantage Infant Formula Milk-Based Powder with Iron, 35 oz, 922 g, with UPC: 078742022468
Hazard: Product may contain metal fragments.
March 20, 2019Food & BeverageFDA
Perrigo Company PLC recalls Simple Truth Organic Banana, Strawberry & Apple Fruit Puree with Nonfat Greek Yogurt, 113 g, packed in a laminate pouch,
Hazard: Perrigo Company is initiating a voluntary recall of one production lot of Simple Truth Organic Banana, Strawberry and Apple Fruit Puree with Nonfat Greek Yogurt, LOT L8159, best by 08/06/2019 due to improper labeling that does not indicate the presence of milk.
February 10, 2016DrugsFDA
Perrigo Company PLC recalls Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0404-15,
Hazard: Labeling: label error on declared strength.
February 10, 2016DrugsFDA
Perrigo Company PLC recalls Nystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0405-05,
Hazard: Labeling: label error on declared strength.
February 3, 2016DrugsFDA
Perrigo Company PLC recalls Guaifenesin DM Cherry liquid (guaifenesin 100 mg/5 mL and Dextromethorphan HBr 5 mg/5 mL), packaged in 4oz. bottles, co-
Hazard: Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.
February 3, 2016DrugsFDA
Perrigo Company PLC recalls Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz. bottles, co-packaged with a dosing cup in a carton and sold under
Hazard: Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.
December 30, 2015DrugsFDA
Perrigo Company PLC recalls Cetirizine HCl 10 mg Tablet, 14 count blister packs, sold over the counter under the following brands, GoodSense brand d
Hazard: Failed Impurity/Degradations Specifications; impurity identified as cetirizine monosaccharide ester